Innovative breast cancer screening for women with dense breast tissue.
Mammography may miss over 1/3 of cancers in dense breasts.1 The InveniaTM ABUS (Automated Breast Ultrasound System) is a comfortable, non-ionizing alternative to other supplemental screening options for women with dense breast tissue. When used in addition to mammography, Invenia ABUS can improve breast cancer detection by 55 percent over mammography* alone.2 Learn more about Invenia ABUS by downloading the brochure.
Why is Invenia ABUS screening needed?
Approximately 40% of American women have dense breasts.3 Having dense breasts can increase a woman's risk to develop cancer by 4-6 times.4 Mammography may miss cancers in dense breasts, Invenia ABUS has been proven to find 55 percent
more invasive cancers after
a normal or benign mammographic finding.
Learn more about breast density by downloading a breast density informational sheet.
What are the steps in an Invenia ABUS exam?
The Invenia ABUS acquisition process uses 3D ultrasound technology to comfortably and quickly image women with dense breast tissue. Each exam takes approximately 15 minutes.
ABUS has been shown to find small, invasive, node-negative cancers that were missed by mammography. ABUS as a supplemental exam is becoming an integral part of many practices.
Anatomy of an ABUS image
ABUS 3D images provide clinicians the ability to thoroughly and efficiently examine breast tissue. The format may seem unfamiliar at first. Learn more about the ABUS image display and image manipulation options below.
*Increase in sensitivity associated with an overall decrease in specificity.
1. Boyd, N.F. et.al. Mammographic Density and the Risk and Detection of Breast Cancer, N Engl J Med 2007;356:227-36.
2. Brem RF, Tabár L, et.al. Assessing Improvement in Detection of Breast Cancer with Three-dimensional Automated Breast US in Women with Dense Breast Tissue: The SomoInsight Study. Radiology. 2015 Mar; 274(3): 663-73.
3. Pisano et al. Diagnostic Performance of Digital versus Film Mammography for Breast -Cancer Screening. NEJM 2005;353:1773
4. et al, NEJM Jan 2007.
Case 45 - 82 yr. old - Annual screening mammographically occult IDC
Case 46 - 54 yr. old - left palpable - IDC incidental finding right lobular carcinoma
Case 47 - 56 yr old - Annual screening mammographically occult IDC
Biopsy proven IDC shown with Invenia ABUS, hand-held ultrasound, mammography and MRI
Clinical evidence is growing about the effectiveness of ultrasound for finding small, node-negative, invasive cancers missed by mammography. Invenia ABUS is designed for the screening environment, specifically for dense breast imaging. Invenia ABUS diminishes operator variability and creates 3D ultrasound volumes to enable comprehensive analysis and comparison to multi-modality exams.
Read the SomoInsight Study, to learn about the effectiveness of ABUS for breast screening. Download the SomoInsight Study
|Dr. Rachel Brem comments on the significance of the study||Dr. Mark Inciardi comments on the clinical benefit of ABUS|
Download the case studies at the right detailing how ABUS helped uncover hidden cancers.
- Automated Breast Ultrasound Clarifies Diagnosis of Subareolar Mass in Dense Breast
- Cancer Detection Improves for Women with Dense Breasts When Automated Breast Ultrasound Screening is Combined with 3D Tomosynthesis
- Mammography plus Automated Breast Ultrasound (ABUS) results in improved earlier detection of breast cancer
- Imaging for Women ABUS Economic Value Case Study
These complimentary webinars feature experienced ABUS users who discuss ABUS in clinical practice.
Dr. Joseph Russo, Section Chief of Women's Imaging, St. Luke's University Health Network, Bethlehem, PA
This presentation outlines an effective way to manage screening in the 'dense breast era' through the development of a personalized screening program utilizing various imaging modalities based on a woman's risk and breast density.
Marc F Inciardi, MD, Assistant Professor of Radiology, Section Head, Breast Imaging, University of Kansas Medical Center
What is breast density? Why it is important to measure? What is its role as an independent risk factor for developing breast cancer? What is its impact on the effectiveness of screening mammography.? Dr. Marc Inciardi will review University of Kansas clinical results using automated breast ultrasound since 2009 for screening women with dense breasts as one of the 12 clinical sites participating in the SomoInsight Clinical Study.
Ian Grady MD, FACS, North Valley Breast Center, Redding, CA
A brief history of various publications supporting the use of handheld ultrasound and Automated Breast Ultrasound (ABUS) as a supplemental screening tool for the dense breast population will be presented. In addition, the integration of ABUS into the breast screening workflow will be explained and various clinical examples will be reviewed.
Monica H Saini MD, MS, Chief of Breast Imaging, Santa Fe Imaging/Christus Medical Center
This presentation reviews the decrease in sensitivity of mammography in dense breasts and the risk associated with breast density. Published clinical results supporting supplemental screening with Automated Breast Ultrasound (ABUS) are featured. Dr. Sani presents her first year experiences in implementing ABUS in a community hospital as a supplemental screening tool for women with dense breasts and reviews interesting ABUS cases.
Beverly E Hashimoto, M.D., FACR, Section Head, Ultrasound, Virginia Mason Medical Center, Seattle, WA
This presentation covers coronal breast scanning and its ability to offer operator independent acquisition, wide field of view, and provide an excellent basis for multi-modality comparisons. Dr. Beverly Hashimoto will review various clinical cases that demonstrate the benefit of the coronal view for breast imaging.
These complementary webinars provide healthcare professionals and introduction to ABUS and the clinical need for this technology.
ABUS users provide their commentary on the clinical need for supplemental screening for dense breasts, and how ABUS has performed in clinical practice.
The clinical need for ABUS
How does ABUS benefit surgeons?
What should be done for patients with dense breasts?
Invenia ABUS patient experience
Patient's provide their impressions of ABUS supplemental screening for dense breasts, and how it has affected them. For more information on breast care for patients, please visit knowyourrisk.gehealthcare.com
ABUS peace of mind
Anatomy of an ABUS Image
Anatomy of an ABUS Image
The appearance of an ABUS image may seem unfamiliar at first. The 4 quadrant, multi-image format allows clinicians great flexibility to investigate various views of tissue or suspicious areas in one display. A collection of orientation tools also help clinicians identify their location and navigate through the tissue.
- Dual volume display (coronal transverse side by side) allows comparison within the same ABUS exam, or with other modality exams.
- Coronal view from skin line to chest wall is adjustable from 0.5 - 10 mm thickness (increments of 0.5 mm).
- Axial view is adjustable from 0.5 - 10 mm thickness (increments of 0.5 mm)
- Nipple marker in each coronal image remains in view to provide constant orientation
Breast body marker
in each quadrant displays the three coordinates of the current region of interest position (clock, distance from
nipple and depth from the skin) thus providing a very precise location of the lesion. This body marker information
helps in targeting the area very quickly with the hand held ultrasound, which is necessary when performing
follow-ups on suspicious findings on the Invenia ABUS.
- Image orientation graphic in each quadrant shows the anatomical location of the volume The graphic is configurable and the lettering represents the anatomical orientations: Anterior, Posterior, Medial, Lateral, Superior and Inferior.
Technology designed for screening.
GE Healthcare is the sole provider of FDA-approved technology designed for screening women with dense breast tissue. From its remarkable architecture to its advanced imaging algorithms, InveniaTM ABUS is engineered for automated screening. Besides increased detection, the Invenia ABUS is designed for reproducibility, ease of use and both patient and operator comfort.
Powerful Imaging Architecture
Invenia ABUS's imaging architecture shifts traditional ultrasound from hardware- to software-based processing, resulting in extraordinary performance for the fast-paced breast imaging environment. With its massive parallel processing power and proprietary beamforming technology, the system creates focus at every pixel, delivering an image of high uniformity and resolution.
Intelligent Imaging Algorithms
Advanced algorithms automate the imaging process to help provide remarkable image quality and reproducibility from user to user, these include: Tissue Equalization, Nipple Shadow Compensation, Breast Border Detection and Chest Wall Detection. All of these are all designed to eliminate the distractions, and focus the radiologist's attention on the most important data - the anatomy.
Operator workflow is smooth and easy with the Invenia ABUS high-resolution touchscreen display's advanced Projective Capacitive Touch (PCT) technology. Its sleek, graphical user interface enhances the way you work. Tap and swipe colorful icons to quickly and easily maneuver through the Invenia ABUS exam.
Transducer shaped for a woman's anatomy
The patented Reverse Curve™ transducer offers extraordinary image performance, enhanced breast coverage and patient comfort. It is an extraordinary new class of transducer design conforms to a woman's anatomy.
The Invenia ABUS provides Compression Assist to the scan head assembly. This feature automatically applies up to 3 levels of compressions to the breast for patient comfort, operator ease and image acquisition quality.
Efficient reading and analysis
Images generated from the Invenia ABUS Scan Station are sent to the Invenia ABUS Workstation for interpretation, enabling fast, quick review and may be archived to PACS or external storage to optimize breast ultrasound workflow.
3D volumes are displayed in a patented, 2 mm thick coronal view slice from the skin to the chest wall using proprietary pattern recognition software. The result is a reading environment which allows for rapid and intuitive analysis of intricate breast anatomy and pathology.
Mastery Training for Physicians and Technologists
The InveniaTM ABUS Mastery Program uses progressive teaching techniques led by our experienced team of peer educators and clinical applications specialists. The program is dedicated to the rapid development of diagnostic confidence to quickly build the clinical skills and experience necessary to effectively use Invenia ABUS.
- No travel necessary - courses are conducted in a peer-to-peer format via remote desktop sharing with live video and audio connections.
- Self-paced web-based tutorials, hands-on casework with a peer educator and self-assessment testing with individualized feedback
- Conducted by an Invenia ABUS clinical applications specialist at your location as part of the Invenia ABUS system installation
- Three full days of didactic teaching and hands-on scanning
- Overview of the Invenia ABUS workstation user interface, basic features and functionality, 3D volume layout, case management, image data storage and reporting
- One-on-one coaching to refine scanning technique and ensure proper positioning
- Review the quality of every scan
- Includes 5 CEUs specific to breast ultrasound. Satisfies the minimum ACR credentialing requirements for ARRTs at ACR Breast Centers of Excellence or ACR Accredited Breast Ultrasound Centers
For more information download the Invenia ABUS Education Information Sheet
Marketing your InveniaTM ABUS screening program
GE Healthcare is committed to your success. As part of your Invenia ABUS investment, we provide a comprehensive set of customizable, professionally designed marketing tools.
You will receive a Marketing Kit that includes sample materials, templates and production files for you to customize and reproduce you to create your own PR and digital/print materials for your practice.
The marketing kit provides tools to help you:
- Inform referring physicians how Invenia ABUS improves early cancer detection for their patients
- Increase patient’s knowledge about breast density with educational tools such as brochures, posters and videos
- Market to women in your community with social media, press releases and other templates to help grow awareness
Invenia ABUS System Consumable Supplies
GE Healthcare offers an array of consumable supplies for the InveniaTM ABUS and somo•vTM ABUS (Automated Breast Ultrasound) Platinum systems including scan membranes, Polysonic® ultrasound lotions and ProtexTM disinfectants.
ABUS Single-Use Stabilization Membrane
The ABUS disposable scan membrane provides comfort to the patient during the 3D image acquisition. The flexible, polyester, mesh fabric stabilizes the breast tissue and enables better image quality during the scan. The membrane is single-use-only which eliminates the risk of cross-contamination and the need for sterilization. Curved membrane dimensions: 229mm (L) x 213mm (W) x 19mm (D).
POLYSONIC® Ultrasound Lotion is an acoustic coupling lotion that is hypo allergenic and has a light pleasing scent
ProtexTM one-step cleaner disinfectant kills more than 30 pathogens including HIV, H1N1 and MRSA, while remaining safe for even the most sensitive surfaces. For your ease and convenience, it is available as a pre-moistened wipe.
Polysonic and Protex are trademarks of Parker Laboratories, Inc. Third party trademarks are the property of their respective owners.
GE Healthcare's AssurePoint Service offering helps enhance the overall total value of ownership of your Invenia ABUS. Download a service information sheet.
Invenia ABUS Acquisition
Invenia ABUS Overview
GE Healthcare is pleased to offer coding and reimbursement support to our customers.
Contact us for information on:• Healthcare Common Procedural Coding System (HCPCS) Codes
• Current Procedural Terminology (CPT) Codes
• Local Coverage Decisions (LCD)
• National Coverage Decisions (NCD)
• Medicare Claims Processing Guidelines
• Coding and Reimbursement Guides
GE Healthcare agrees to abide by the provisions of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and any other relevant state or federal privacy laws and regulations concerning the use and/or disclosure of protected health information during the course of providing this support. CPT CODES are copy righted by the American Medical Association.
Find a Facility
Find an ABUS Scanning facility in your area
Early detection of breast cancer enables treatment to be started earlier in the course of the disease, possibly before it has spread. Advocate for your health and learn more about ABUS. Use the GE Healthcare ABUS Locator application to find a facility in your area.